Acute treatment effects on GFR in randomized clinical trials of kidney disease progression
<p><strong>Background:</strong> Acute changes in glomerular filtration rate (GFR) can occur following initiation of interventions for chronic kidney disease (CKD) progression. These complicate the interpretation of treatment effects on long term progression of (CKD). We sought to a...
Main Authors: | Neuen, B, Tighiouart, H, Heerspink, HJL, Herrington, W |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Nephrology
2021
|
Similar Items
-
Renal end points in clinical trials of kidney disease
by: Weldegiorgis, M, et al.
Published: (2015) -
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
by: Inker, LA, et al.
Published: (2023) -
Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
by: Vonesh, E, et al.
Published: (2019) -
Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
by: Hirst, J, et al.
Published: (2018) -
In CKD, the kidney failure risk equation predicted 2-y risk for ESKD better than eGFR alone
by: Aguilar-Ramirez, D, et al.
Published: (2022)